Physician profile
William Beneke
NPI 1023164522
$710.47
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.19 · 2020: $16.43 · 2023: $477 · 2024: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $655.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $222.53 | 2023-2024 | Xarelto |
| Philips North America LLC | $98.00 | 2020-2023 | |
| Novo Nordisk INC | $85.23 | 2023-2024 | Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $78.92 | 2023-2024 | Eliquis, Camzyos |
| Boston Scientific Corporation | $78.64 | 2023-2024 | Watchman Flx |
| Kiniksa Pharmaceuticals International, Plc | $27.52 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $24.97 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.15 | 2023 | |
| Amgen INC. | $20.40 | 2023 | Repatha |
| Sanofi-Aventis U.S. LLC | $14.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.92 | 2024 | |
| Medtronic Vascular, INC. | $12.39 | 2019 | |
| Braemar Manufacturing, LLC | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Beneke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.